中文产业新闻评分49Chinese source
默沙东与阿斯利康在两天内达成两笔20亿美元级BD交易，涉及KRAS G12D抑制剂和PD-1/VEGF双抗
2天2笔20亿美元级BD
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
2天2笔20亿美元级BD
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.